Earnings Summary: EyePoint (EYPT) Q4 2025 net loss widens
EyePoint, Inc. (NASDAQ: EYPT), which is engaged in the development of therapeutics for retinal diseases, on Wednesday announced financial results...
6 articles, transcripts, and reports
EyePoint, Inc. (NASDAQ: EYPT), which is engaged in the development of therapeutics for retinal diseases, on Wednesday announced financial results...
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Q2 2022 Earnings Conference
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Q1 2022 Earnings Conference
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Q4 2021 Earnings Conference
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Q3 2021 Earnings Conference
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Q2 2021 Earnings Conference